L. Lanier
Immunology · 2000–2022
A researcher in the Science corpus: 19 papers; trusts 12 researchers and is trusted by 51 researchers here, as inferred from the citation graph.
Subfields
- Immunology — 182 citations into it; #41 of 2,160 by trust here, #227 by citations
- Oncology — 40 citations into it; #867 of 1,698 by trust here, #952 by citations
- Molecular Biology — 31 citations into it
- Radiology, Nuclear Medicine and Imaging — 7 citations into it; #1,573 of 3,265 by trust here, #1,399 by citations
Whom L. Lanier trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- J. Ravetch
- D. Raulet
- A. Diefenbach
- Amanda M. Jamieson
- W. Yokoyama
- A. Cerwenka
- Y. Bryceson
- A. Moretta
- G. Trinchieri
- M. Smyth
Who trusts L. Lanier overall
- Joseph C. Sun
- M. Call
- Eric O Long
- D. Raulet
- R. Medzhitov
- D. Pardoll
- Y. Bryceson
- É. Vivier
- C. Fischer
- I. Waldhauer
Papers from L. Lanier's perspective
Ordered by how strongly the researchers L. Lanier trusts endorse each paper. Same corpus, a different order for every researcher.
- ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. (Immunity)
- Immune inhibitory receptors. (Science)
- Molecular basis of celiac disease. (Annual Review of Immunology)
- Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. (The Lancet)
- Now You See It, Now You Don't (Science's STKE)
- Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. (Blood)
- Early Programming of T Cell Populations Responding to Bacterial Infection1 (Journal of Immunology)
- Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells (Nature)
- Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection. (Immunity)
- Effector and memory CTL differentiation. (Annual Review of Immunology)
Their papers
- CD69 acts downstream of interferon-α/β to inhibit S1P1 and lymphocyte egress from lymphoid organs (2006) — 818 citations
- Multiple early factors anticipate post-acute COVID-19 sequelae (2022) — 994 citations
- Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients (2019) — 650 citations
- NK cells and cancer: you can teach innate cells new tricks (2015) — 1,046 citations
- Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function. (2012) — 639 citations
- NK cell development, homeostasis and function: parallels with CD8+ T cells (2011) — 677 citations
- Innate or Adaptive Immunity? The Example of Natural Killer Cells (2011) — 2,683 citations
- Expansion of a unique CD57+NKG2Chi natural killer cell subset during acute human cytomegalovirus infection (2011) — 775 citations
- CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. (2010) — 757 citations
- Adaptive Immune Features of Natural Killer Cells (2009) — 1,606 citations
- Up on the tightrope: natural killer cell activation and inhibition (2008) — 1,677 citations
- CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. (2006) — 642 citations
- NK cell recognition. (2005) — 3,037 citations
- Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. (2004) — 889 citations
- Direct Recognition of Cytomegalovirus by Activating and Inhibitory NK Cell Receptors (2002) — 1,331 citations
- Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo (2001) — 680 citations
- Natural killer cells, viruses and cancer (2001) — 949 citations
- Fcα/μ receptor mediates endocytosis of IgM-coated microbes (2000) — 299 citations
- Immune inhibitory receptors. (2000) — 1,403 citations